Dilemma-Solving PIC Vesicles: Ligand-Driven Assembly of Stable yet Degradable Nanocarriers for Cytosolic Protein Delivery
Source abstract
Abstract
Polyion complex (PIC) vesicles represent a promising platform for protein therapeutics delivery, yet balancing extracellular stability with intracellular degradability remains challenging. Herein, we present a ligand-engineering strategy to fabricate dual-functional PIC vesicles. The design centers on a disulfide bridged bis-dipicolinic acid ligand, L2(S-S), which chelates with Gd3+ at a stoichiometric ratio of 1:3 to form anionic branched coordination polymers. These polymers coassemble with cationic PEG113-b-PMETAC73 diblock copolymers, creating uniform vesicles capable of in situ protein loading while preserving their structure and bioactivity. The branched architecture ensures extracellular stability of the vesicle and effective cargo shielding. However, upon cellular internalization, the high intracellular glutathione concentration triggers the reductive cleavage of disulfide bonds, leading to rapid polymer degradation, vesicle disassembly, and subsequent cytoplasmic protein release. Notably, while both GSH-responsive and nonresponsive vesicles facilitated efficient cytosolic delivery, only the degradable vesicles induced significant tumor suppression, underscoring the critical role of cytoplasmic protein release for therapeutic efficacy. This ligand-engineering approach resolves the stability-degradability paradox and provides a general design principle for intelligent protein delivery systems.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State-Key Laboratory of Chemical Engineering, and Shanghai Key Laboratory of Multiphase Materials Chemical Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, People’s Republic of China
Department of Orthopedics, Changzheng Hospital
Naval Medical University
Funding
Recruitment Program of Global Experts
References (63)
Show source-provided references
1. 10.1038/s41467-023-38039-x10.1038/s41467-023-38039-x ↗
2. 10.1038/s41551-021-00698-w10.1038/s41551-021-00698-w ↗
3. 10.1021/acs.accounts.1c0076610.1021/acs.accounts.1c00766 ↗
4. 10.7150/thno.4700710.7150/thno.47007 ↗
5. 10.1021/acsnano.9b0419810.1021/acsnano.9b04198 ↗
6. 10.1021/acs.biomac.1c0074510.1021/acs.biomac.1c00745 ↗
7. 10.1021/acs.chemmater.3c0224210.1021/acs.chemmater.3c02242 ↗
8. 10.1021/jacs.2c0409610.1021/jacs.2c04096 ↗
9. 10.1002/anie.20130288110.1002/anie.201302881 ↗
10. 10.1038/s41557-021-00866-010.1038/s41557-021-00866-0 ↗
11. 10.1038/s41467-018-05384-110.1038/s41467-018-05384-1 ↗
12. 10.1002/anie.20131124510.1002/anie.201311245 ↗
13. 10.1021/jacs.1c0377810.1021/jacs.1c03778 ↗
14. 10.1021/jacs.8b1174710.1021/jacs.8b11747 ↗
15. 10.1002/adfm.20250573810.1002/adfm.202505738 ↗
16. 10.1002/adma.20240532310.1002/adma.202405323 ↗
17. 10.1021/acsami.6b1413210.1021/acsami.6b14132 ↗
18. 10.1021/acs.nanolett.1c0215010.1021/acs.nanolett.1c02150 ↗
19. 10.1002/adfm.20201055610.1002/adfm.202010556 ↗
20. 10.31635/ccschem.020.20200022410.31635/ccschem.020.202000224 ↗
21. 10.1021/jacs.7b0121410.1021/jacs.7b01214 ↗
22. 10.1021/acscentsci.8b0003510.1021/acscentsci.8b00035 ↗
23. 10.1002/anie.20150833910.1002/anie.201508339 ↗
24. 10.3390/polym1209195310.3390/polym12091953 ↗
25. 10.1007/s12274-021-3396-x10.1007/s12274-021-3396-x ↗
26. 10.1021/la303211b10.1021/la303211b ↗
27. 10.1039/B815884C10.1039/B815884C ↗
28. 10.1016/j.jconrel.2025.11368310.1016/j.jconrel.2025.113683 ↗
29. 10.1016/j.colsurfb.2017.07.04210.1016/j.colsurfb.2017.07.042 ↗
30. 10.1039/b909934d10.1039/b909934d ↗
31. 10.1021/acs.macromol.9b0057110.1021/acs.macromol.9b00571 ↗
32. 10.1021/ja406992w10.1021/ja406992w ↗
33. 10.1039/C7PY00304H10.1039/C7PY00304H ↗
34. 10.1039/D4SM00216D10.1039/D4SM00216D ↗
35. 10.1016/S0040-4020(03)00753-110.1016/S0040-4020(03)00753-1 ↗
36. 10.1063/1.492168610.1063/1.4921686 ↗
37. 10.1002/jsfa.1410910.1002/jsfa.14109 ↗
38. Misono T. · 2019 · 5910.1007/978-981-13-5931-6_9 ↗
39. 10.1021/jp508935510.1021/jp5089355 ↗
40. 10.1002/anie.20190351310.1002/anie.201903513 ↗
41. 10.1021/jacs.6b0454810.1021/jacs.6b04548 ↗
42. 10.3390/polym1712160810.3390/polym17121608 ↗
43. 10.1038/s41565-019-0417-y10.1038/s41565-019-0417-y ↗
44. 10.1021/jp100320910.1021/jp1003209 ↗
45. 10.1002/ejic.20040009810.1002/ejic.200400098 ↗
46. 10.1002/adfm.20210872910.1002/adfm.202108729 ↗
47. 10.3390/gels908061110.3390/gels9080611 ↗
48. 10.1021/la035012n10.1021/la035012n ↗
49. 10.1016/j.biomaterials.2021.12078010.1016/j.biomaterials.2021.120780 ↗
50. 10.1021/acsnano.0c0557410.1021/acsnano.0c05574 ↗
51. 10.1021/jp071814610.1021/jp0718146 ↗
52. 10.1016/j.cis.2008.09.01210.1016/j.cis.2008.09.012 ↗
53. 10.3390/antiox1205109410.3390/antiox12051094 ↗
54. 10.1021/jacs.0c0787010.1021/jacs.0c07870 ↗
55. 10.1039/C9OB00541B10.1039/C9OB00541B ↗
56. 10.1039/D4BM01440E10.1039/D4BM01440E ↗
57. 10.1021/acscentsci.8b0016810.1021/acscentsci.8b00168 ↗
58. 10.1038/s41467-019-12906-y10.1038/s41467-019-12906-y ↗
59. 10.1083/jcb.20180416110.1083/jcb.201804161 ↗
60. 10.1038/nbt134010.1038/nbt1340 ↗
61. Russo A. · Cancer Res. · 1986 · 46 · 2845
62. 10.1021/ja803741f10.1021/ja803741f ↗
63. 10.1021/ja057993r10.1021/ja057993r ↗